ABOUT PERKINELMER, INC.

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our innovative informatics and service capabilities, combined with deep market knowledge and expertise, help customers gain earlier and more accurate insights to improve lives and the world around us. PerkinElmer is the exclusive distributor for both TIBCO Spotfire® and Attivio® for scientific and clinical R&D applications.

FEATURED PRODUCTS

PerkinElmer Signals™ Medical Review PerkinElmer Signals™ Medical Review

See our exciting new solution for medical monitors, PerkinElmer Signals™ Medical Review which empowers clinical development teams and medical monitors to detect safety signals faster and reduce time to submission by combining innovative medical review workflow with advanced analytics.

PerkinElmer Risk-Based Monitoring Solution PerkinElmer Risk-Based Monitoring Solution

The PerkinElmer Risk-Based Monitoring Solution is the most effective way to leverage data-driven insights to optimize site performance while improving patient safety.

WEBINARS

Avoid Missing Critical Safety Signals In Your Trials Video Avoid Missing Critical Safety Signals In Your Trials Video

Protect the safety of trials subjects and give medical monitors the ability to increase the quality and speed of their work with this solution.

Signals™ Medical Review, Safety Signal Detection, Faster Submission Signals™ Medical Review, Safety Signal Detection, Faster Submission

Medical monitors are overwhelmed by the sheer volume and variety of data they need to sort through to find, investigate, and react to safety signals. To reduce the risk of missing a safety issue and protect trial subjects, monitors need a way to quickly and easily find what they need, without having to hunt through irrelevant data. PerkinElmer Signals Medical Review is purpose-built for medical monitors, enabling them to detect safety signals faster and easier. With the innovative combination of targeted workflow and industry-leading analytics, Signals Medical Review reduces the overall time to submission without compromising safety.

Predict And Act On Site Risks With Data-Driven Insights Predict And Act On Site Risks With Data-Driven Insights

This webcast discusses how central monitors can leverage guided visual analytics to find and act on the right site issues quickly without sifting through mounds of operational and site data.

Uncover Pharmacovigilance Insights With Data Discovery And Active Surveillance Uncover Pharmacovigilance Insights With Data Discovery And Active Surveillance

This webcast discusses how drug safety teams can use dynamic visual analytics to uncover safety issues earlier. All the while, complying with extremely complex and ever-evolving regulatory requirements.

Propel Medical Review With Guided Analytics Propel Medical Review With Guided Analytics

This webcast discusses how medical monitors can leverage guided visual analytics to find and act on the right issues quickly without sifting through mounds of clinical data.

CONTACT INFORMATION

PerkinElmer, Inc.

940 Winter Street

Waltham, MA 02451

UNITED STATES

Phone: 508-331-9014

Contact: Rob Rittberg

FEATURED ARTICLES

  • Which Door To RBM Adoption?
    Which Door To RBM Adoption?

    Overcoming the many known barriers to adopting and implementing an RBM program.

  • To Insource Or Not To Insource: What Is Your Best Clinical Analytics Strategy?
    To Insource Or Not To Insource: What Is Your Best Clinical Analytics Strategy?

    What to consider when making this important strategic decision.

  • King Arthur’s Excalibur in ICH E6 (r2)
    King Arthur’s Excalibur in ICH E6 (r2)

    What is the medical monitor's role in the latest ICH E6 (r2) guidance and how to get them to adopt technology that will help them experience tangible efficiency and quality gains.

  • Are Safety Signals Overlooked In Clinical Trials?
    Are Safety Signals Overlooked In Clinical Trials?

    In this interview, Jennifer Prichard, MD, Medical Monitor at Atlantic Research Group, and Hunter Walker, CTO at Atlantic Research Group (a CRO) will discuss challenges with existing medical monitoring processes, and how new technologies can help improve efficiency.

  • Adapting To The Medical Monitor: Driving Tech Adoption In Clinical Analytics
    Adapting To The Medical Monitor: Driving Tech Adoption In Clinical Analytics

    The reasons behind the physician monitors’ reluctance, and what technology needs to offer to convince monitors their work can be more efficient — quickly detecting safety signals and speeding time to submission.

  • Avoid Missing Critical Safety Signals In Your Trials Video
    Avoid Missing Critical Safety Signals In Your Trials Video

    Protect the safety of trials subjects and give medical monitors the ability to increase the quality and speed of their work with this solution.

  • Cloud-Based PerkinElmer Signals Medical Review Helps Clinical Development Teams Reduce Risks, Time To Submission

    PerkinElmer, Inc., a global leader committed to innovating for a healthier world, recently announced the launch of PerkinElmer Signals Medical Review.

  • Do THIS To Shorten Your Clinical Trial
    Do THIS To Shorten Your Clinical Trial

    With sponsors facing increasing pressure to reduce drug prices and bring therapies to patients faster, follow these tips to shorten your clinical development process.

  • Unlock Historical Data To Enrich RBM Insights
    Unlock Historical Data To Enrich RBM Insights

    The data landscape for clinical operations is complex and comprised of many disparate sources, so a data agnostic solution is essential for full access and visibility into the data. Without an intuitive visual analytics tool, it becomes impossible to navigate data hierarchies and gain meaningful insights into the data.

  • Medical Monitors Fear This The Most
    Medical Monitors Fear This The Most

    Insights from medical monitors about the obstacles they face and their impact on the overall study conduct, operational efficiency, and most importantly, subject safety.

  • Transforming Clinical Development
    Transforming Clinical Development

    To enable the completion of clinical trials as safely, efficiently and quickly as possible, PerkinElmer Informatics’ clinical solutions streamline clinical trial data visualization and analysis with real-time access to clinical data in all phases of clinical development.

  • Clinical Data Aggregation
    Clinical Data Aggregation

    Learn about the challenges for Sponsors and CROs when integrating a vast array of data sources, typical relational database structures and why they don’t work for clinical analytics,  as well as the ideal clinical data aggregation solutions for continuous, automatic data consolidation.

  • Achieving Clinical Operations Excellence
    Achieving Clinical Operations Excellence

    Learn how PerkinElmer’s clinical solutions give clinical operations organizations the unprecedented ability to reduce the time, cost and risk of running clinical trials while accelerating the time to market for products across the entire portfolio of clinical candidates.

  • Speeding The Switch To Risk-Based Monitoring
    Speeding The Switch To Risk-Based Monitoring

    The adoption of RBM is increasing as companies provide greater management support, staff training and more sophisticated technology systems. Technology platforms that enable continuous monitoring with near real-time intuitive visualizations, analytic dashboards and applications will allow issues to be identified and addressed early, improving study safety and efficiency.

  • The Foundation Of Risk-Based Monitoring Success
    The Foundation Of Risk-Based Monitoring Success

    Proponents of RBM projects believe that the investment in this approach will return an overall reduction in monitoring expense by 15 to 20 percent. This paper discusses RBM as a high-value use case that can be enhanced by a robust clinical data aggregation and analytics solution.

  • Planning Quality Into Clinical Trials: Integrating RBM And QbD
    Planning Quality Into Clinical Trials: Integrating RBM And QbD

    Drug developers are focusing significant attention on risk-based monitoring (RBM) of clinical trials to improve data quality, trial efficiency and patient safety. Widely encouraged by regulatory agencies, RBM adoption is gradually building momentum as sponsors and contract research organizations (CROs) concentrate on developing the right strategies, deploying the most effective technologies and internally managing change.

  • Solutions For The Strategic Assessment Of Clinical Data In Trial Operations
    Solutions For The Strategic Assessment Of Clinical Data In Trial Operations

    Achieve clinical trial operations excellence using this an innovative solution that gives clinical operations organizations the unprecedented ability to reduce the time, cost, and risk of running clinical trials while accelerating time to market for products across the entire portfolio of clinical candidates.

  • Placing The Patient First In Clinical Trials
    Placing The Patient First In Clinical Trials

    This article discusses ways to adopt patient-centered drug development, changing the corporate culture and trial design, understanding patient needs and incorporating them into trials, and leveraging technology to conduct remote patient-centric clinical trials.